Neon Therapeutics’ Personal Neoantigen Vaccine study (NT-001) demonstrated prolonged progression-free survival in advanced or metastatic melanoma, non-small cell lung cancer bladder cancers. The investigational drug, NEO-PV-01, in combination with OPDIVO (nivolumab),...